Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review

被引：66

作者：

Gerbens, L. A. A. ^{[1
]}

Prinsen, C. A. C. ^{[2
]}

Chalmers, J. R. ^{[3
]}

Drucker, A. M. ^{[4
,5
]}

von Kobyletzki, L. B. ^{[6
]}

Limpens, J. ^{[7
]}

Nankervis, H. ^{[3
]}

Svensson, A. ^{[6
]}

Terwee, C. B. ^{[2
]}

Zhang, J. ^{[8
]}

Apfelbacher, C. J. ^{[9
]}

Spuls, P. I. ^{[1
]}

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

[2] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands

[3] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham, England

[4] Univ Hlth Network, Div Dermatol, Toronto, ON, Canada

[5] Brown Univ, Dept Dermatol, Providence, RI 02912 USA

[6] Lund Univ, Inst Clin Sci, Dept Dermatol, Malmo, Sweden

[7] Acad Med Ctr, Med Lib, Amsterdam, Netherlands

[8] Peking Univ, Peoples Hosp, Dept Dermatol, Beijing, Peoples R China

[9] Univ Regensburg, Inst Epidemiol & Prevent Med, Med Sociol, Regensburg, Germany

来源：

ALLERGY | 2017年 / 72卷 / 01期

关键词：

atopic eczema; core outcome set; Harmonising Outcome Measures for Eczema (HOME) initiative; measurement properties; symptoms; PATIENT-ORIENTED SCORAD; OUTCOME MEASURES; DERMATITIS SEVERITY; CLINICAL-TRIALS; INITIAL VALIDATION; ITCH SEVERITY; PO-SCORAD; QUALITY; QUESTIONNAIRE; SCALE;

D O I：

10.1111/all.12959

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

BackgroundSymptoms have been identified as a core outcome domain for atopic eczema (AE) trials. Various instruments exist to measure symptoms in AE, but they vary in quality and there is a lack of standardization between clinical trials. Our objective was to systematically evaluate the quality of the evidence on the measurement properties of AE symptom instruments, thereby informing consensus discussions within the Harmonising Outcome Measures for Eczema (HOME) initiative regarding the most appropriate instruments for the core outcome domain symptoms. MethodsUsing the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist and predefined criteria for good measurement properties on identified development and validation studies of AE symptom instruments, a best evidence synthesis was performed to draw an overall conclusion on quality of the instruments and to provide recommendations. ResultsEighteen instruments were identified and evaluated. When the quality and results of the studies were considered, only five of these instruments had sufficient validation data to consider them for the core outcome set for the core outcome domain symptoms. These were the paediatric Itch Severity Scale (ISS), Patient-Oriented Eczema Measure (POEM), Patient-Oriented SCOring Atopic Dermatitis (PO-SCORAD), Self-Administered Eczema Area and Severity Index (SA-EASI) and adapted SA-EASI. ConclusionsISS (paediatric version), POEM, PO-SCORAD, SA-EASI and adapted SA-EASI are currently the most appropriate instruments and therefore have the potential to be recommended as core symptom instrument in future clinical trials. These findings will be utilized for the development of a core outcome set for AE.

引用

页码：146 / 163

页数：18

共 47 条

[1]

[Anonymous], ACTA DERM VENEREOL

[2]

[Anonymous], 2004, Dermatol Psychosom

[3] Atopic Dermatitis [J].

Bieber, Thomas .

ANNALS OF DERMATOLOGY, 2010, 22 (02) :125-137

[4]

Boers M, 1998, J RHEUMATOL, V25, P198

[5] The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool [J].

Carel, Kirstin ;

Bratton, Donna L. ;

Miyazawa, Naomi ;

Gyorkos, Elizabeth ;

Kelsay, Kimberly ;

Bender, Bruce ;

Strand, Matthew ;

Atkins, Dan ;

Gelfand, Erwin W. ;

Klinnert, Mary D. .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 101 (05) :500-507

[6] Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) [J].

Chalmers, J. R. ;

Simpson, E. ;

Apfelbacher, C. J. ;

Thomas, K. S. ;

von Kobyletzki, L. ;

Schmitt, J. ;

Singh, J. A. ;

Svensson, A. ;

Williams, H. C. ;

Abuabara, K. ;

Aoki, V. ;

Ardeleanu, M. ;

Awici-Rasmussen, M. ;

Barbarot, S. ;

Berents, T. L. ;

Block, J. ;

Bragg, A. ;

Burton, T. ;

Clemmensen, K. K. Bjerring ;

Creswell-Melville, A. ;

Dinesen, M. ;

Drucker, A. ;

Eckert, L. ;

Flohr, C. ;

Garg, M. ;

Gerbens, L. A. A. ;

Graff, A. L. B. ;

Hanifin, J. ;

Heinl, D. ;

Humphreys, R. ;

Ishii, H. A. ;

Kataoka, Y. ;

Leshem, Y. A. ;

Marquort, B. ;

Massuel, M. -A. ;

Merhand, S. ;

Mizutani, H. ;

Murota, H. ;

Murrell, D. F. ;

Nakahara, T. ;

Nasr, I. ;

Nograles, K. ;

Ohya, Y. ;

Osterloh, I. ;

Pander, J. ;

Prinsen, C. ;

Purkins, L. ;

Ridd, M. ;

Sach, T. ;

Schuttelaar, M. -L. A. .

BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (01) :69-79

[7] Measuring atopic dermatitis severity in randomized controlled clinical trials: What exactly are we measuring? [J].

Charman, C ;

Chambers, C ;

Williams, H .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (06) :932-941

[8] Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods [J].

Charman, C. R. ;

Venn, A. J. ;

Ravenscroft, J. C. ;

Williams, H. C. .

BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (06) :1326-1332

[9] The patient-oriented eczema measure - Development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective [J].

Charman, CR ;

Venn, AJ ;

Williams, HC .

ARCHIVES OF DERMATOLOGY, 2004, 140 (12) :1513-1519

[10]

Charman D, 1999, J Outcome Meas, V3, P21

← 1 2 3 4 5 →